http://www.unboundmedicine.com/medline/ebm/research/irinotecanUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19893292/full_citation/Histological_complete_response_in_a_case_of_advanced_gastric_endocrine_carcinoma_treated_by_irinotecan_plus_cisplatin_Kirishima T, Yoshinami N, Marui A, et al. 
Histological complete response in a case of advanced gastric endocrine carcinoma treated by irinotecan plus cisplatin. [Journal Article]
Nippon Shokakibyo Gakkai Zasshi 2009 Nov; 106(11):1616-24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890960/full_citation/An_animal_model_for_chemotherapy_associated_steatohepatitis_and_its_prevention_by_the_oral_administration_of_fatty_acid_bile_acid_conjugate_Keizman D, Maimon N, Ish-Shalom M, et al. 
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate. [JOURNAL ARTICLE]
Cancer 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890692/full_citation/Docetaxel:_its_role_in_current_and_future_treatments_for_advanced_gastric_cancer_Nishiyama M, Wada S 
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19888427/full_citation/Transarterial_Chemoembolization_of_Metastatic_Colorectal_Carcinoma_with_Drug_Eluting_Beads_Irinotecan__DEBIRI_:_Multi_Institutional_Registry_Martin RC, Joshi J, Robbins K, et al. 
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. [Journal Article]
J Oncol 2009.:539795.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886993/full_citation/Transarterial_chemoembolisation__TACE__using_irinotecan_loaded_beads_for_the_treatment_of_unresectable_metastases_to_the_liver_in_patients_with_colorectal_cancer:_an_interim_report_Martin RC, Robbins K, Tomalty D, et al. 
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. [JOURNAL ARTICLE]
World J Surg Oncol 2009 Nov 3; 7(1):80.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19885570/full_citation/The_role_of_protein_kinase_C_in_the_synergistic_interaction_of_safingol_and_irinotecan_in_colon_cancer_cells_Ling LU, Lin H, Tan KB, et al. 
The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells. [JOURNAL ARTICLE]
Int J Oncol 2009 Dec; 35(6):1463-1471.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884803/full_citation/A_Phase_I_Study_of_Flavopiridol_in_Combination_With_Gemcitabine_and_Irinotecan_in_Patients_With_Metastatic_Cancer_Fekrazad HM, Verschraegen CF, Royce M, et al. 
A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer. [JOURNAL ARTICLE]
Am J Clin Oncol 2009 Oct 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19884549/full_citation/KRAS_and_BRAF_Mutations_in_Advanced_Colorectal_Cancer_Are_Associated_With_Poor_Prognosis_but_Do_Not_Preclude_Benefit_From_Oxaliplatin_or_Irinotecan:_Results_From_the_MRC_FOCUS_Trial_Richman SD, Seymour MT, Chambers P, et al. 
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19883083/full_citation/4_Pregnen_21_ol_320_dione_21__4_bromobenzenesufonate___NSC_88915__and_Related_Novel_Steroid_Derivatives_as_Tyrosyl_DNA_Phosphodiesterase__Tdp1__Inhibitors_Dexheimer TS, Gediya LK, Stephen AG, et al. 
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors. [JOURNAL ARTICLE]
J Med Chem 2009 Nov 2.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881975/full_citation/Heterogeneity_of_adenosine_triphosphate_based_chemotherapy_response_assay_in_colorectal_cancer__secondary_publication_Huh JW, Park YA, Lee KY, et al. 
Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication. [Journal Article]
Yonsei Med J 2009 Oct 31; 50(5):697-703.
Abstract | Full Citation